This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr 15;87(8):1032-4.

doi: 10.1016/s0002-9149(01)01543-0.

Tachyphylaxis in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

PMID: 11327075
DOI: 10.1016/s0002-9149(01)01543-0

Comment

Tachyphylaxis in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

P H Jones. Am J Cardiol. 2001.

. 2001 Apr 15;87(8):1032-4.

doi: 10.1016/s0002-9149(01)01543-0.

Author

PMID: 11327075
DOI: 10.1016/s0002-9149(01)01543-0

No abstract available

PubMed Disclaimer

Comment on

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
Jones P, Kafonek S, Laurora I, Hunninghake D. Jones P, et al. Am J Cardiol. 1998 Mar 1;81(5):582-7. doi: 10.1016/s0002-9149(97)00965-x. Am J Cardiol. 1998. PMID: 9514454 Clinical Trial.
Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors.
Cromwell WC, Ziajka PE. Cromwell WC, et al. Am J Cardiol. 2000 Nov 15;86(10):1123-7. doi: 10.1016/s0002-9149(00)01171-1. Am J Cardiol. 2000. PMID: 11074211

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information